1. Academic Validation
  2. Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and in vitro assessment of breast cancer cytotoxicity

Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and in vitro assessment of breast cancer cytotoxicity

  • Colloid Interface Sci Commun. 2019 Jan;28:69-74. doi: 10.1016/j.colcom.2018.12.002.
Justin G Rosch 1 Hayden Winter 2 Allison N DuRoss 1 Gaurav Sahay 1 3 Conroy Sun 1 4
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Science, Oregon State University, 2730 SW Moody Ave, Portland, OR, 97201, USA.
  • 2 Department of Chemistry, Portland State University, 1719 SW 10th Ave, Portland, OR, 97201, USA.
  • 3 Department of Biomedical Engineering, 2730 SW Moody Ave, Oregon Health & Science University, Portland, OR 97201, USA.
  • 4 Department of Radiation Medicine, 3181 S.W. Sam Jackson Park Rd, Oregon Health & Science, University, Portland, OR 97239, USA.
Abstract

Naturally-derived Polysaccharides, such as alginate and chitosan, can be assembled to form nanocarriers for the delivery of therapeutic agents. Here we exploit the electrostatic complexation of alginate/chitosan in a water-in-oil (w/o) emulsion process to produce doxorubicin (DOX)-loaded nanoparticles (~80 nm) with exceptional spherical morphology and uniformity. This robust synthetic route utilizes an aqueous phase dispersed in a cyclohexane/dodecylamine organic phase and is capable of encapsulating DOX in the nanoparticle solution. The uptake and efficacy of this novel formulation was evaluated in a murine breast Cancer cell line, 4T1, with comparable 72 h IC50 values of the nanoparticle solution (0.15 μg/mL) and free DOX (0.13 μg/mL). Overall, the favorable performance, physiochemical properties, and their facile production support these nanocarriers as promising platform for the delivery of aqueous soluble drugs.

Keywords

alginate; breast cancer; cell viability; chitosan; doxorubicin.

Figures
Products